Italy's Chiesi Farmaceutici to buy Amryt Pharma in a $1.48 billion deal

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 08, 2023 at 10:22: PM
via Italy's Chiesi Farmaceutici said on Sunday it will acquire Ireland-based drugmaker Amryt Pharma Plc , which has products and drugs in development for treating rare diseases, in a deal valued at $1.48 billion.

article source
 

<



Similar threads

cafead
BioMarin Narrows Roctavian Efforts to U.S., Germany, Italy as Sales Stagnate
Replies
0
Views
41
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Replies
0
Views
26
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Italy sees hike in biotech R&amp;D investments, at rate higher than EU average
Replies
0
Views
102
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on...
Replies
0
Views
170
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
[release] SIFI Appoints New Country Manager for Italy
Replies
0
Views
183
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote